1-8 of 8
Juergen Kuball
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML

Clinical Trials & Observations
Bob Löwenberg, Thomas Pabst, Johan Maertens, Yvette van Norden, Bart J. Biemond, Harry C. Schouten, Olivier Spertini, Edo Vellenga, Carlos Graux, Violaine Havelange, Georgine E. de Greef, Okke de Weerdt, Marie-Cecile J. C. Legdeur, Juergen Kuball, Marinus van Marwijk Kooy, Bjorn T. Gjertsen, Mojca Jongen-Lavrencic, Arjan A. van de Loosdrecht, Daniëlle van Lammeren-Venema, Beata Hodossy, Dimitri A. Breems, Yves Chalandon, Jakob Passweg, Peter J. M. Valk, Markus G. Manz, Gert J. Ossenkoppele
Journal: Blood
Blood (2017) 129 (12): 1636–1645.
https://doi.org/10.1182/blood-2016-10-740613
Published: 2017
Includes: Supplemental data
Journal Articles

Peptide Vaccination Against Cytomegalovirus (CMV) Elicits Immunological and Clinical Responses after Allogeneic Stem Cell Transplantation Even from a CMV Seronegative Donor

Michael Schmitt, MD, Anita Schmitt, MD, Markus Wiesneth, Angela Hückelhoven, PhD, Zeguang Wu, Juergen Kuball, MD, Lei Wang, Peter Schauwecker, MD, Susanne Hofmann, Marlies Götz, Birgit Michels, Birgit Maccari, Patrick Wuchter, MD, Thomas Mertens, MD, Paul Schnitzler, MD, Hartmut Döhner, MD, Anthony D. Ho, MD, Donald Bunjes, Peter Dreger, MD, Hubert Schrezenmeier, MD, Jochen Greiner
Journal: Blood
Blood (2016) 128 (22): 2519.
https://doi.org/10.1182/blood.V128.22.2519.2519
Published: 2016
Journal Articles

The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA

Clinical Trials & Observations
Richard F. Schlenk, Erdogan Taskesen, Yvette van Norden, Jürgen Krauter, Arnold Ganser, Lars Bullinger, Verena I. Gaidzik, Peter Paschka, Andrea Corbacioglu, Gudrun Göhring, Andrea Kündgen, Gerhard Held, Katharina Götze, Edo Vellenga, Juergen Kuball, Urs Schanz, Jakob Passweg, Thomas Pabst, Johan Maertens, Gert J. Ossenkoppele, Ruud Delwel, Hartmut Döhner, Jan J. Cornelissen, Konstanze Döhner, Bob Löwenberg
Journal: Blood
Blood (2013) 122 (9): 1576–1582.
https://doi.org/10.1182/blood-2013-05-503847
Published: 2013
Includes: Supplemental data
Journal Articles

Improving Tumor Immunotherapy by Using Distinct Subpopulations of the γδT Cell Repertoire with High Anti-Tumor Reactivity.

Suzanne van Dorp, MD, Samantha Hol, Victoria Marcu-Malina, PhD, Nicole Thuss, Henk Lokhorst, MD, PhD, Juergen Kuball, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4504.
https://doi.org/10.1182/blood.V114.22.4504.4504
Published: 2009
Journal Articles

B- Cell Depletion as Therapy for Steroid Refractory Chronic Gvhd Is Most Effective for Sclerosis of the Skin.

Suzanne van Dorp, MD, Henk Lokhorst, MD, PhD, Eefke Petersen, MD, PhD, Monique C. Minnema, MD, PhD, Lambert F. Span, MD, PhD, Saskia Ebeling, PhD, Marijke van Dijk, MD, PhD, Ellen Meijer, MD, PhD, Juergen Kuball, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2232.
https://doi.org/10.1182/blood.V114.22.2232.2232
Published: 2009
Journal Articles

Increasing Functional Avidity of T Cell Receptor (TCR)-Redirected T Cells by Removing Defined N-Glycoslyation Sites in the Constant Domain of Introduced TCR Chains.

Juergen Kuball, Beate Hauptrock, Matthias Wolfl, Ralf Holger Voss, PhD, Roland Strong, Matthias Theobald, Phil Greenberg
Journal: Blood
Blood (2007) 110 (11): 2764.
https://doi.org/10.1182/blood.V110.11.2764.2764
Published: 2007
Journal Articles

Playing the Game Together: Coexpression of a Single Chain T Cell Receptor and a T Cell Receptor Constant-Alpha Domain Triggers Tumor Reactivity.

Simone Thomas, MD, Ralf H. Voss, PhD, Ratna Intan, Renate Engel, Juergen Kuball, MD, Christoph Huber, MD, Matthias Theobald, MD
Journal: Blood
Blood (2006) 108 (11): 3716.
https://doi.org/10.1182/blood.V108.11.3716.3716
Published: 2006
Journal Articles

Vaccination with WT1 and PR3 Derived Peptides in Patients with AML/MDS and MUC1 Peptides in Patients with Multiple Myeloma - Preliminary Results.

Eva M. Wagner, Juergen Kuball, MD, Mohamed Wattad, MD, Christoph Huber, MD, Wolfgang Heit, MD, Matthias Theobald, MD
Journal: Blood
Blood (2006) 108 (11): 4582.
https://doi.org/10.1182/blood.V108.11.4582.4582
Published: 2006